| Titre : | Cannabis and mental illness: a review (2019) |
| Auteurs : | D. J. E. LOWE ; J. D. SASIADEK ; A. S. COLES ; T. P. GEORGE |
| Type de document : | Article : Périodique |
| Dans : | European Archives of Psychiatry and Clinical Neuroscience (Vol.269, n°1, February 2019) |
| Article en page(s) : | 107-120 |
| Langues: | Anglais |
| Discipline : | PSY (Psychopathologie / Psychopathology) |
| Mots-clés : |
Thésaurus mots-clés CANNABIS ; PSYCHOPATHOLOGIE ; SCHIZOPHRENIE ; PSYCHOSE ; TROUBLES DE L'HUMEUR ; ANXIETE ; ETAT DE STRESS POST-TRAUMATIQUE ; POPULATION A RISQUE ; FACTEUR DE VULNERABILITE ; LEGALISATION ; SANTE MENTALE ; FACTEUR DE RISQUE ; DEPRESSION |
| Résumé : | With the increasing push to legalize cannabis in Western nations, there is a need to gage the potential impact of this policy change on vulnerable populations, such as those with mental illness, including schizophrenia, mood, and anxiety disorders. This is particularly important as there are strong motives in these individuals to seek short-term reward (e.g., "getting high"). Nonetheless, data to support the beneficial effects of cannabis use in psychiatric populations are limited, and potential harms in patients with psychotic and mood disorders have been increasingly documented. This article reviews the effects of cannabis in people with mental illness. Then, we provide a reconciliation of the addiction vulnerability and allostatic hypotheses to explain co-morbidity addiction in mentally ill cannabis users, as well as to further aid in developing a rational framework for the assessment and treatment of problematic cannabis use in these patients. |
| Domaine : | Drogues illicites / Illicit drugs |
| Sous-type de document : | Revue de la littérature / Literature review |
| Refs biblio. : | 154 |
| Affiliation : | Addictions Division, Centre for Addiction and Mental Health (CAMH), University of Toronto, Toronto, USA |
Accueil
